Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Launch Of Zoledronic Acid Injection


Thursday, 4 Apr 2013 01:09am EDT 

Dr.Reddy's Laboratories Ltd announced that it has launched Zoledronic Acid Injection (5 mg/100 mL), a bioequivalent generic version of Reclast (zoledronic acid) 5mg/100mL Injection in the US market on April 3, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Zoledronic Acid Injection (5 mg/100 mL). 

Company Quote

3054.35
16.3 +0.54%
10:16am EDT